Search Stock News and Analysis

Options Pop on Outperforming Gilead Stock After Trump Touts Treatment

https://www.schaeffersresearch.com/content/options/2020/03/19/options-pop-on-outperforming-gilead-stock-after-trump-touts-treatment

3/19/2020 3:16 PM

While most stocks have bottomed out as the inescapable coronavirus-sparked selloff rages on, biotech name Gilead Sciences, Inc. (NASDAQ:GILD) has been a notable outperformer. The stock is up 3.4% at ...

Drug Stock Puts Trendline Support to the Test

https://www.schaeffersresearch.com/content/bgs/2020/03/10/drug-stock-puts-trendline-support-to-the-test

3/10/2020 2:25 PM

With the major U.S. indexes suffering their worst week since the financial crisis of 2008 in late February, it should be non-trivial to say coronavirus – or COVID-19 – has become a massive caveat to n...

FTSV Stock Attracts Options Bulls, Analysts

https://www.schaeffersresearch.com/content/options/2020/03/03/ftsv-stock-attracts-options-bulls-analysts

3/3/2020 2:31 PM

Drugmaker Forty Seven Inc (NASDAQ:FTSV) hit yet another all-time high of $94.68 today, and was last seen up 0.3% at $94.22. This comes just one day after its impressive 61% surge during yesterday's ...

Options Players Go After GILD, ORCL, and TJX Stocks

https://www.schaeffersresearch.com/content/options/2020/02/26/options-players-go-after-gild-orcl-and-tjx-stocks

2/26/2020 2:07 PM

Three names seeing unusual options activity today are Gilead Sciences, Inc. (NASDAQ:GILD), Oracle Corporation (NYSE:ORCL), and TJX Companies Inc (NYSE:TJX). Below we'll break down why options trade...

Analyst: This Drug Name is a "Top Pick"

https://www.schaeffersresearch.com/content/news/2019/07/29/analyst-this-drug-name-is-a-top-pick

7/29/2019 9:13 AM

Shares of drugmaker Gilead Sciences, Inc. (NASDAQ:GILD) are up 1.5% in pre-market trading, after the stock received an upgrade to "top pick" from "outperform" out of RBC. The brokerage firm cited new...

PEOPLE ALSO SEARCH FOR